N3Cure

Company Overview

Snapshot

Founded in March 2019 by Sagi Moran, N3Cure operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its CROSSITOL system to enhance plastic manufacturing processes.

Business overview

N3Cure specializes in developing and manufacturing transformative additive masterbatches for the plastic industry. Its core technology, the CROSSITOL system, combines an additive with a UV energy source to create a controlled crosslinking reaction. This innovation aims to reduce raw material usage by approximately 50%, improve product performance, and optimize manufacturing processes by fitting smoothly into existing production lines. N3Cure primarily serves markets within industrial manufacturing, specifically targeting discrete industries like packaging and containers, and process industries such as plastics, with a focus on clean manufacturing, climate tech, and sustainable materials.

Company Intelligence Q&A

What is N3Cure's primary product or technology?

N3Cure's primary product is the CROSSITOL system, which consists of an additive and a UV energy source designed to create a crosslinking reaction in plastics manufacturing.

What problem does N3Cure's CROSSITOL system address in the plastic industry?

The CROSSITOL system aims to reduce raw material usage by approximately 50%, enhance product performance, and improve the manufacturing process by optimizing thermal and mechanical properties, enabling conversion to a single polymer, and achieving desired depth.

How does N3Cure's technology impact manufacturing efficiency and sustainability?

N3Cure's UV crosslinking device integrates into existing manufacturing lines, reducing production time, water and energy costs, and the overall carbon footprint, contributing to eco-efficient manufacturing.

When was N3Cure founded?

N3Cure was founded in March 2019.

Who is a co-founder of N3Cure?

Sagi Moran is a co-founder and the CEO of N3Cure.